Paroven: not much effect in trials

1992 ◽  
Vol 30 (2) ◽  
pp. 7-8

The Medicines Control Agency has recently restricted the licensed uses of Paroven (Zyma*) to ‘relief of symptoms of oedema associated with chronic venous insufficiency’. A mixture of oxerutins, Paroven had long been marketed for the relief of symptoms ‘associated with venous insufficiency, including painful heavy tired legs, night cramps, paraesthesia, restless legs, varicose states, and post-phlebitic syndrome’. Much work on the drug has been published since 1970, when we concluded that despite interesting pharmacological actions the evidence for its therapeutic value was poor.1 Is there now a clear rationale for its use?

2020 ◽  
Vol 35 (10) ◽  
pp. 771-776
Author(s):  
Atıf Yolgösteren ◽  
Leyla Köse Leba ◽  
Aylin Bican Demir

Background We aimed to investigate of chronic venous insufficiency on patients with sleep disorder due to restless legs syndrome. Method Five hundred forty-one cases on whom polysomnography was performed due to sleep disorder were evaluated retrospectively. Forty patients with restless legs syndrome were determined. They were examined by history, physical examination, and duplex ultrasonography in terms of chronic venous insufficiency. The sleep stage rates of both groups were compared (that the rate of total sleep time in polysomnography to sleep stages is expressed as minute and percentage has been defined as sleep stage rate). Result Chronic venous insufficiency was identified in 20 out of 40 patients (group 1; female, 90%). In group 2, there were patients with only restless legs syndrome but with no chronic venous insufficiency (female, 80%). The mean ages of both groups were 56.4 ± 11.8 and 54.3 ± 14.7 years. Stage 1 sleep rate in group 1 was 5% ± 2.7 and in group 2 was 8% ± 3.8 (p = 0.006). Periodic limb movement index (polysomnography finding evaluating involuntary leg movements during sleep) was 11.4 ± 17.5 in group 1, and it was 29.4 ± 37.9 in group 2 (p = 0.006). Conclusion We recommend that chronic venous insufficiency should be investigated in patients with primary restless legs syndrome diagnosis.


Phlebologie ◽  
2000 ◽  
Vol 29 (02) ◽  
pp. 48-53 ◽  
Author(s):  
M. Jünger ◽  
Anke Steins

ZusammenfassungWenn Maßnahmen der physikalischen Therapie wie rezeptpflichtige Kompressionsstrümpfe und ein angeleitetes ambulantes Gefäßtraining in einem frühen Stadium begonnen werden, können die Beschwerden des Patienten gelindert, die Gelenkbeweglichkeit und venöse Drainage verbessert und behindernde Stauungserkrankungen wie die Dermatolipofasziitis und das Ulcus cruris vermieden werden. Hat eine chronische venöse Stauung einmal zu einer Atrophie der Gelenkkapsel, Sprunggelenksversteifung und Muskelatrophie des Unterschenkels geführt, sind teure Therapiemaßnahmen einschließlich einer professionellen Krankengymnastik unumgänglich. Unseren eigenen Erfahrungen nach ist eine krankengymnastische Behandlung am wirksamsten, wenn sie in Kombination mit einer biomechanischen Stimulation erfolgt. Sobald der Steppergang des Patienten behoben wurde, können herkömmliche Gehübungen nach und nach das physiologische Gangbild wiederherstellen. Nach erfolgreicher Physiotherapie tragen ein ambulantes Gefäßtraining und eine optimierte Kompressionsbehandlung bei Patienten mit fortgeschrittener chronisch venöser Insuffizienz entscheidend zum langfristigen Therapieerfolg bei. Vergleichbar dem Koronarsport werden Gefäßtrainingsprogramme von den öffentlichen Kassen übernommen. Zusammen mit einer Kompressionsbehandlung stellen sie eine wirksame und kosteneffektive Basistherapie für die chronisch venöse Insuffizienz dar.


Medic ro ◽  
2018 ◽  
Vol 1 (121) ◽  
pp. 46
Author(s):  
Cristina Vâjâitu ◽  
Teodora Mareş ◽  
Carmen Cristina Drăghici ◽  
Vlad Mihai Voiculescu ◽  
Călin Giurcăneanu

2020 ◽  
pp. 64-75
Author(s):  
E. Burleva ◽  
O. Smirnov ◽  
S. Tyurin

The purpose of the study was to conduct a comparative assessment of the course of the postoperative period after phlebectomy and thermal ablation in patients with varicose veins of the lower extremities in the system of the great saphenous vein (GSV) with class C2 of chronic venous insufficiency (CVI) — CEAP class C2. Materials and methods: 455 patients (455 limbs) with CEAP class C2. Group 1 (n = 154) received stripping + minimally invasive phlebectomy; Group 2 — endovenous laser ablation (EVLA) of GSV trunk + sclerotherapy of varicose veins; 3 group (n = 150) — radiofrequency ablation (RFA) of the GSV + sclerotherapy. All patients were united by a single tactical solution — the elimination of pathological vertical reflux in GSV. In each group, patients were with similar hemodynamic profile were selected (Group 1 = 63; Group 2 = 61; Group 3 = 61). The course of the postoperative period (from 2 days to 2 months) was compared for pain (visual analog scale — VAS), clinical symptoms of chronic venous insufficiency, degree of satisfaction (Darvall questionnaire), and duration of disability. Statistical processing was carried out using Excel programs for Windows XP, MedCalc® (version 11.4.2.0., Mariakerke, Belgium). Results: Postoperative pain is more pronounced (during day 1 for Group 1–4.0, Group 2–3.0, Group 3–2.0) and more prolonged (up to 4 days) after open surgeries (p < 0.05). The dynamics of the clinical symptoms of CVI (including varicose syndrome and use of compression therapy) could not be fully evaluated in connection with the ongoing sclerotherapy procedures for patients of Groups 2 and 3. Satisfaction of patients with aesthetic aspects was higher than expected in all groups. Reliable statistical differences proved decrease in days of disability (Group 1–14; Group 2–4; Group 3–3) and earlier return to physical activities and work in patients after thermal ablation in comparison with phlebectomy. Conclusion: The study shows that all three methods for eliminating vertical reflux in the GSV can be proposed for a large category of patients with CEAP of class C3 and C2. Medical and social rehabilitation of patients using endovascular thermal ablation technologies proceeds faster, which is beneficial both for the patients and for society.


2008 ◽  
Vol 4 (1) ◽  
pp. 117-124
Author(s):  
Pier L. Antignani ◽  
Chiara Caliumi

Vascular ◽  
2021 ◽  
pp. 170853812110296
Author(s):  
Mustafa Aldemir ◽  
Ahmet Yuksel ◽  
Mehmet Inanir ◽  
Salih Metin ◽  
Yusuf Velioglu ◽  
...  

Objective Platelet distribution width (PDW) has been reported in a wide range of pathological settings. In this study, we aimed to investigate the relationship between PDW and lower extremity chronic venous insufficiency (CVI) by comparing the levels of PDW and other parameters derived from complete blood count (CBC) tests in young individuals with or without lower extremity CVI. Methods This prospective clinical study was conducted between January 2020 and December 2020. A total of 108 patients, 72 patients with lower extremity CVI (study group) and 36 healthy volunteers (control group) were enrolled from the Bursa Yuksek Ihtısas Educatıon Research Hospıtal and the Bolu Abant Izzet Baysal University Training and Research Hospital. The age range of the participants was between 18 and 50 years old. Participants’ baseline clinical features and CBC parameters including PDW, white blood cell, hemoglobin, hematocrit, mean corpuscular volume, red cell distribution width, neutrophil, lymphocyte, platelet count, mean platelet volume, plateletcrit, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were compared between the two groups. Results The groups were statistically similar in terms of baseline clinical features. The median PDW value was significantly higher for the CVI patients relative to the control group (17.6 vs 16.8; p < 0.001). In terms of other CBC parameters, there were no significant differences between the groups. According to ROC analysis, area under the curve of PDW was 0.749 (95% confidence interval: 0.653–0.846 and p < 0.001). If the value of PDW was accepted as 17, it could predict CVI with 76% sensitivity and 59% specificity, whereas a PDW value of 17.5 could predict CVI with 51% sensitivity and 81% specificity. Conclusion Platelet distribution width might be a useful marker to determine an increased inflammatory response and thrombotic status in young patients with CVI.


Sign in / Sign up

Export Citation Format

Share Document